SCHEMBL6026352

SCHEMBL6026352

COc1ccc(C(O)c2ccc(OCC(=O)O)cc2)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.55
THRB P10828 1/20 0.55
LMNA P02545 2/20 0.51
TSHR P16473 2/20 0.49
ALDH1A1 P00352 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
BCHE P06276 1/20 0.44
TYR P14679 1/20 0.44
ACHE P22303 1/20 0.44
POLB P06746 3/20 0.44
GAA P10253 1/20 0.44
HSD17B10 Q99714 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3145891 0.86 THRA (0.57) THRATHRBLMNATSHRALDH1A1
SCHEMBL3507489 0.86 THRA (0.57) THRATHRBLMNATSHRALDH1A1
SCHEMBL3507493 0.86 THRA (0.57) THRATHRBLMNATSHRALDH1A1
SCHEMBL9323967 0.83 ALDH1A1 (0.59) LMNATSHRALDH1A1GAASMN1; SMN2
SCHEMBL10686479 0.83 LMNA (0.54) LMNAALDH1A1NPC1BCHETYR
SCHEMBL2519102 0.83 THRA (0.52) THRATHRBLMNATSHRALDH1A1
SCHEMBL16335562 0.81 BCHE (0.43) THRATHRBLMNAALDH1A1BCHE
SCHEMBL2516365 0.81 MAPT (0.52) LMNAALDH1A1BCHETYRACHE
SCHEMBL131893 0.80 LMNA (0.49) LMNAALDH1A1NPC1BCHETYR
SCHEMBL6550407 0.80 MEN1 (0.48) LMNABCHETYRACHEGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020027737-A1 A SOLID-SUPPORTED HYDROXY AMINO ACID AND A SOLID-SUPPORTED AMINO ALCOHOL AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-02-06 WO disclosed
US-20140343227-A1 Diketopiperazine Forming Dipeptidyl Linker LONZA AG (CH) 2014-11-20 US disclosed
US-20140343227-A1 Diketopiperazine Forming Dipeptidyl Linker LONZA AG (CH) 2014-11-20 US disclosed
US-8802819-B2 Diketopiperazine forming dipeptidyl linker LONZA LTD. (CH) 2014-08-12 US disclosed
US-8802819-B2 Diketopiperazine forming dipeptidyl linker LONZA LTD. (CH) 2014-08-12 US disclosed
WO-2012055509-A1 DIKETOPIPERAZINE FORMING DIPEPTIDYL LINKER LONZA LTD (CH) 2012-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343227-A1 Diketopiperazine Forming Dipeptidyl Linker FAP, IAPP, DNPEP THRA 4309/4885THRB 4377/4885LMNA 2112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.